Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 4/2001

Content (7 Articles)

ORIGINAL ARTICLE

CD80 (B7-1) expression on human acute myeloid leukaemic cells cultured with GM-CSF, IL-3 and IL-6

Christine Hicks, Elizabeth Keoshkerian, Leonie Gaudry, Robert Lindeman

ORIGINAL ARTICLE

Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cells to be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes

Arabella Mazzocchi, Cecilia Melani, Licia Rivoltini, Chiara Castelli, Michele Del Vecchio, Claudia Lombardo, Mario P. Colombo, Giorgio Parmiani

ORIGINAL ARTICLE

Role of adhesion molecules in recruitment of Vδ1 T cells from the peripheral blood to the tumor tissue of esophageal cancer patients

M. Loui Thomas, Rajan A. Badwe, Ramakant K. Deshpande, Urmila C. Samant, Shubhada V. Chiplunkar

ORIGINAL ARTICLE

Perforin and granzyme B induce apoptosis in FasL-resistant colon carcinoma cells

David Vermijlen, Christopher J. Froelich, Dianzhong Luo, Nathalie Suarez-Huerta, Bernard Robaye, Eddie Wisse

LETTER TO THE EDITOR

A mesothelioma that is sensitive to locally applied IL-2

Z. Krastev, V. Koltchakov, N. Vladov, D. Popov, A. Milev, J. W. Koten, W. Den Otter

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine